CN Stock MarketDetailed Quotes

600671 Hangzhou Tianmushan Pharmaceutical Enterprise

Watchlist
  • 6.41
  • -0.19-2.88%
Market Closed Sep 13 15:00 CST
780.60MMarket Cap-23394P/E (TTM)

Hangzhou Tianmushan Pharmaceutical Enterprise Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Hangzhou Tianmushan Pharmaceutical Enterprise Q2 2024 Earnings Date

Currency：CNYAug 30, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
31.81M
--
+10.84%
Net Income
--
-8.79M
--
+35.71%
Analyst Rating
No Data

Hangzhou Tianmushan Pharmaceutical Enterprise Earnings Estimates

Revenue

EPS

EBIT

No Data

Hangzhou Tianmushan Pharmaceutical Enterprise Earnings Reports

  • Hangzhou Tianmushan Pharmaceutical Co., Ltd. 2024 Semi-Annual Report

    Aug 29 12:00 ET

  • Summary of the 2024 semi-annual report of Hangzhou Tianmusan Pharmaceutical Co., Ltd.

    Aug 29 12:00 ET

  • Hangzhou Tianmu Mountain Pharmaceutical Co., Ltd. 2024 semi-annual performance forecast.

    Jul 9 12:00 ET

  • Announcement on the Correction of Accounting Errors in the First Quarter Report of Hangzhou Tianmushan Pharmaceutical Co., Ltd. for 2024.

    Jun 4 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg

    No Data